Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.3
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Operating Activities:      
Net Income (Loss) $ (22,970) $ (89,369) $ (14,656)
Adjustments to reconcile net loss to cash used in operating activities      
Depreciation, amortization, and non-cash lease interest   9,543 6,308
Provision for doubtful accounts (155) (566) 299
Reserve for excess and obsolete inventory   331 374
Change in fair value of warrant liabilities   (220) (1,221)
Change in fair value of contingent earnout liability 656 2,509 (50,982)
Amortization (accretion) of (discounts) premiums on available-for-sale securities   (725) 0
Stock-based compensation expense   10,158 15,620
Long-lived asset impairment   4,015 0
Goodwill impairment 0 29,467 0
Changes in operating assets and liabilities      
Accounts receivable   7,497 (3,137)
Inventory   (2,764) (12,178)
Prepaid expenses   671 339
Other current assets   25 (2,202)
Other assets   (392) (939)
Accounts payable and accrued expenses   (3,809) 242
Other current liabilities   44 (114)
Deferred revenue   (72) 909
Other long term liabilities   (612) 0
Other non-current lease liabilities   (5,755) (3,979)
Net cash provided by (used in) operating activities   (40,024) (65,317)
Investing Activities:      
Purchases of property and equipment   (2,176) (5,995)
Cash paid for acquisitions, net of cash acquired   0 (35,634)
Purchases of available-for-sale securities   (18,950) 0
Proceeds from sales and maturities of marketable securities   35,500 0
Net cash provided by (used in) investing activities   14,374 (41,629)
Financing Activities:      
Acquisition Holdback Payment   (250) 0
Proceeds from the exercise of common stock options   187 2,081
Taxes paid related to net share settlement of equity awards   (305) (482)
Net cash provided by (used in) provided by financing activities   (368) 1,599
Effect of exchange rate changes on cash   (58) (21)
Net change in cash, cash equivalents, and restricted cash   (26,076) (105,368)
Cash and cash equivalents and restricted cash      
Beginning of year   125,672 288,603
End of period 183,235 99,596 183,235
Supplemental disclosures of cash flow information      
Cash and cash equivalents 181,805 98,166 181,805
Restricted cash in other non-current assets 1,430 1,430 1,430
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 183,235 99,596 183,235
Non-cash financing and investing activities      
Purchase of property and equipment in accounts payable and accrued expenses   133 2,733
Common stock issued for acquisitions 9,840 0 12,944
Additions to right of use assets and liabilities   0 36,451
Common stock issued to settle acquisition holdback $ 0 $ 250 $ 0